Publications by authors named "V V Moroz"

Claim this Profile
D
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.
Juliet C Gray, Rebekah Weston, Cormac Owens, Adela Canete, Marion Gambart, Veronica Moroz

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Oncolytic Vesicular Stomatitis Virus Expressing Mouse Interleukin-12 and Granulocyte-Macrophage Colony-Stimulating Factor (rVSV-dM51-mIL12-mGMCSF) for Immunotherapy of Lung Carcinoma.
Anastasia Ryapolova, Margarita Zinovieva, Kristina Vorona, Bogdan Krapivin, Vasiliy Moroz

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms.
Justin Watts, Mark D Minden, Kimo Bachiashvili, Andrew M Brunner, Sameem Abedin, Veronica Moroz

Ther Adv Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EFFECT OF DIRECT SURGICAL REVASCULARIZATION ON CEREBRAL HEMODYNAMICS AND STROKE DEVELOPMENT IN PATIENTS WITH MOYAMOYA DISEASE.
O Harmatina, V Moroz

Georgian Med News· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant VSVs: A Promising Tool for Virotherapy.
K A Vorona, V D Moroz, N B Gasanov, A V Karabelsky

Acta Naturae· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis